Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Jaeb Center for Health Research: Clinical Trials & FDA Approval Profile

Jaeb Center for Health Research (Global / Institutional) sponsors 21 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 11 active protocols (6 recruiting now), 6 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)19.1%
Median Closed Enrollment vs National (145 pts)75 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Jaeb Center for Health Research
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)21
Active Pipeline (Recruiting Now)11 (6)
Completed vs Stopped Early6 / 4 (19.1%)
Median Closed Actual Enrollment75 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Jaeb Center for Health Research
Hospital Research SiteLocationShared Protocols
Northwestern Memorial and Lurie Cancer CenterChicago, IL12
Mayo Clinic RochesterRochester, MN10
Stanford Health Care and Stanford Cancer InstituteStanford, CA9

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Jaeb Center for Health Research
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT06524882Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of AgePhase IIIRECRUITING
NCT04378790A Randomized Trial to Evaluate Sequential vs Simultaneous PatchingPhase IIIRECRUITING
NCT06790784Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDRPhase IIIRECRUITING
NCT05844982Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due toPhase IIIRECRUITING
NCT06380517Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of AgePhase IIIRECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the Jaeb Center for Health Research Interactive Dossier, benchmark peers in Endocrinology, Obesity, and Metabolic, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI